Rotavirus strain surveillance--an Australian perspective of strains causing disease in hospitalised children from 1997 to 2007

Vaccine
Carl D KirkwoodRuth F Bishop

Abstract

This study documents rotavirus strains causing severe disease in Australian children during the pre-vaccine era. During the period 1997-2007, rotavirus strains from national multi-centre hospital-based surveillance in Australia were analysed for G and P types. G1P[8] was the dominant genotype identified during the 11-year study, with intermittent peaks associated with genotypes G2P[4], G3P[8] and G9P[8]. The results provide baseline information of the G and P genotypes causing disease in Australian children, and highlight the unpredictable changes in genotype incidence that can occur on both a local and national level. To be optimally effective, rotavirus vaccines must prevent disease caused by all common rotavirus genotypes.

References

May 11, 1984·Nucleic Acids Research·M L Dyall-Smith, I H Holmes
Jul 18, 2000·Journal of Medical Virology·M Iturriza-GómaraJ Gray
Mar 31, 2005·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Mustafizur RahmanMarc Van Ranst
Jan 6, 2006·The New England Journal of Medicine·Guillermo M Ruiz-PalaciosUNKNOWN Human Rotavirus Vaccine Study Group
Nov 1, 2006·Australian and New Zealand Journal of Public Health·John C GalatiJohn B Carlin
Feb 9, 2008·Emerging Infectious Diseases·Ricardo Q GurgelCharles A Hart
Feb 15, 2008·Journal of Clinical Microbiology·S SharmaM K Bhan
Apr 2, 2008·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Mirjam Kühne SimmondsMiren Iturriza-Gómara
Jun 24, 2008·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Ricardo Q GurgelLuis E Cuevas
Jul 8, 2008·Archives of Virology·Jelle MatthijnssensMarc Van Ranst

❮ Previous
Next ❯

Citations

May 27, 2014·Journal of Tropical Pediatrics·Adolfine HokororoStephen E Mshana
Apr 22, 2011·Journal of the Royal Society, Interface·Virginia E PitzerBryan T Grenfell
Aug 6, 2010·The Pediatric Infectious Disease Journal·Alexis de RougemontUNKNOWN French Rotavirus Network
Dec 18, 2013·The Pediatric Infectious Disease Journal·Nicholas M KiuliaAtunga Nyachieo
Jul 3, 2010·Paediatric Drugs·Keith GrimwoodRichard J Milne
Feb 19, 2011·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Marcelo Takahiro MituiKamruddin Ahmed
Oct 4, 2011·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·A Sánchez-FauquierI Wilhelmi
Nov 26, 2013·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Slavica Mijatovic-RustempasicMichael D Bowen
May 28, 2014·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Celeste M DonatoCarl D Kirkwood
Aug 26, 2014·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Celeste M DonatoCarl D Kirkwood
Jun 12, 2016·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·A de RougemontUNKNOWN French National Rotavirus Network
Nov 21, 2007·Vaccine·Anthony T NewallC Raina MacIntyre
Jul 19, 2019·Communicable Diseases Intelligence·Susie Roczo-FarkasUNKNOWN the Australian Rotavirus Surveillance Group

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.